Works matching AU Mahipal, Amit
Results: 76
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994
- By:
- Publication type:
- Article
Analysis of Registered Clinical Trials in Gastroenterology, 2007-2019.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 7, p. e2221770, doi. 10.1001/jamanetworkopen.2022.21770
- By:
- Publication type:
- Article
Analysis of Registered Clinical Trials in Gastroenterology, 2007-2019.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 7, p. 1, doi. 10.1001/jamanetworkopen.2022.21770
- By:
- Publication type:
- Article
Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical Trials.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 229, doi. 10.3390/biomedicines13010229
- By:
- Publication type:
- Article
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2020, v. 14, n. 7, p. 619, doi. 10.1080/17474124.2020.1777856
- By:
- Publication type:
- Article
Fatal Pulmonary Toxicity After a Single Dose of Cyclophosphamide.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 4, p. 616, doi. 10.1592/phco.27.4.616
- By:
- Publication type:
- Article
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 10335, doi. 10.2147/OTT.S214870
- By:
- Publication type:
- Article
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 10463, doi. 10.2147/CMAR.S208720
- By:
- Publication type:
- Article
Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 9, p. 1834, doi. 10.1002/cncr.21357
- By:
- Publication type:
- Article
Effect of Age on Clinical Outcomes in Phase 1 Trial Participants.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2015, v. 22, n. 2, p. 235, doi. 10.1177/107327481502200217
- By:
- Publication type:
- Article
EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.
- Published in:
- Oncology, 2017, v. 92, n. 4, p. 190, doi. 10.1159/000452766
- By:
- Publication type:
- Article
Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer.
- Published in:
- Oncology, 2014, v. 87, n. 2, p. 125, doi. 10.1159/000361051
- By:
- Publication type:
- Article
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 71, doi. 10.36401/JIPO-24-8
- By:
- Publication type:
- Article
Long-term Survival in Patients with Advanced Hepatocellular Cancer with Dual Immunotherapy Agents: Tremelimumab Plus Durvalumab.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 2, doi. 10.17925/ohr.2024.20.1.1
- By:
- Publication type:
- Article
Durvalumab: A PD-L1 Blocking Antibody for the Treatment of Adult Patients with Locally Advanced or Metastatic Biliary Tract Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 22, doi. 10.17925/OHR.2023.19.1.22
- By:
- Publication type:
- Article
Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1197288
- By:
- Publication type:
- Article
Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151632
- By:
- Publication type:
- Article
Metastatic Colon Cancer Presenting With Immune-mediated Necrotizing Myopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of Registered Clinical Trials in Surgical Oncology, 2008-2020.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2145511, doi. 10.1001/jamanetworkopen.2021.45511
- By:
- Publication type:
- Article
A case of acquired hemophilia associated with bullous pemphigoid.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 6, p. 502, doi. 10.1002/ajh.20890
- By:
- Publication type:
- Article
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date.
- Published in:
- OncoTargets & Therapy, 2024, v. 17, p. 383, doi. 10.2147/OTT.S391707
- By:
- Publication type:
- Article
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5145, doi. 10.2147/OTT.S272208
- By:
- Publication type:
- Article
The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia.
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 6, p. 352, doi. 10.1007/s11912-010-0122-3
- By:
- Publication type:
- Article
Acquired hemophilia in chronic lymphocytic leukemia.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 5, p. 1026, doi. 10.1080/10428190701203962
- By:
- Publication type:
- Article
An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma.
- Published in:
- Expert Opinion on Pharmacotherapy, 2022, v. 23, n. 17, p. 1879, doi. 10.1080/14656566.2022.2138331
- By:
- Publication type:
- Article
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
- By:
- Publication type:
- Article
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1072, doi. 10.1007/s10637-021-01090-w
- By:
- Publication type:
- Article
Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 473, doi. 10.1007/s10637-018-0676-8
- By:
- Publication type:
- Article
Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1093, doi. 10.1007/s10637-015-0277-8
- By:
- Publication type:
- Article
Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 481, doi. 10.1007/s00280-015-2814-8
- By:
- Publication type:
- Article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody targeting the DR5 receptor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 887, doi. 10.1007/s00280-015-2712-0
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study.
- Published in:
- Oncologist, 2024, v. 29, n. 11, p. 986, doi. 10.1093/oncolo/oyae142
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
- By:
- Publication type:
- Article
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 510, doi. 10.1093/oncolo/oyad009
- By:
- Publication type:
- Article
A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1893, doi. 10.1634/theoncologist.2020-0759
- By:
- Publication type:
- Article
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1681, doi. 10.1634/theoncologist.2020-0086
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 380, doi. 10.1634/theoncologist.2019-0874
- By:
- Publication type:
- Article
HHV-8-Associated Multicentric Castleman's Disease in HIV-Negative Patient: A Novel Therapy for an Orphan Disease.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.
- Published in:
- Medical Oncology, 2012, v. 29, n. 1, p. 134, doi. 10.1007/s12032-010-9802-y
- By:
- Publication type:
- Article
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2407, doi. 10.3390/cancers16132407
- By:
- Publication type:
- Article
Outcome of Patients with Locally Advanced Rectal Cancer Pursuing Non-Surgical Strategy in National Cancer Database.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2194, doi. 10.3390/cancers16122194
- By:
- Publication type:
- Article
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1861, doi. 10.3390/cancers16101861
- By:
- Publication type:
- Article
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1823, doi. 10.3390/cancers16101823
- By:
- Publication type:
- Article
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 684, doi. 10.3390/cancers16040684
- By:
- Publication type:
- Article
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4867, doi. 10.3390/cancers15194867
- By:
- Publication type:
- Article
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3570, doi. 10.3390/cancers15143570
- By:
- Publication type:
- Article